- 111.7k views
Cardiometabolic case on Diabetes: Know Diabetes By Heart
Diabetes produces acute and chronic toxicity to vascular endothelium in the patients resulting in spikes in hyperglycemia due to exposure to postprandial glucose. This causes microvascular and macrovascular complications.Damage to blood vessels starts early in such conditions.CVD and diabetes are interrelated,treatment focuses on the shared pathophysiologic mechanism of the diseases.
About the Speaker

Dr Amit Kumar Dey
Apollo Sugar Clinics, Newtown, Kolkota
Upcoming Case Discussions
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Genetic Screening and Its Role in Embryo Selection for IVF
Genetic screening plays a crucial role in the process of embryo selection for in vitro fertilization (IVF) by identifying potential genetic disorders in embryos before implantation. This screening, often referred to as preimplantation genetic testing (PGT), involves analyzing embryos for chromosomal abnormalities or specific genetic mutations. It helps in selecting the healthiest embryos, reducing the risk of passing on inherited conditions, and increasing the chances of a successful pregnancy. PGT can identify conditions such as Down syndrome, cystic fibrosis, and certain inherited cancers, allowing parents to make informed decisions about which embryos to implant. This technology enhances the overall outcome of IVF by improving the quality of embryos and reducing the likelihood of miscarriage. Ultimately, genetic screening offers a valuable tool for optimizing reproductive success and promoting healthier pregnancies.
Congenital Uterine Anomalies
Congenital uterine anomalies are structural abnormalities of the uterus resulting from improper fusion, canalization, or resorption of the Müllerian ducts during fetal development. These anomalies include septate, bicornuate, unicornuate, and didelphys uterus, among others. They can be asymptomatic or associated with infertility, recurrent pregnancy loss, preterm birth, or abnormal menstruation. Diagnosis is typically made using imaging modalities like ultrasound, MRI, or hysterosalpingography. Treatment depends on the type and severity of the anomaly, with surgical correction such as hysteroscopic septum resection often indicated in symptomatic cases. Early detection is crucial for optimizing reproductive outcomes and guiding appropriate management strategies.
Management of Postoperative Pain: Best Practices for GP’s
Effective management of postoperative pain is crucial for promoting recovery and preventing complications. General practitioners should start by assessing pain severity using appropriate scales, then tailor the treatment plan based on the patient's medical history and the type of surgery. A combination of pharmacological approaches, such as non-opioid analgesics (e.g., NSAIDs) and opioids when necessary, should be used to minimize pain while reducing the risk of addiction. Multimodal strategies, including physical therapy and non-pharmacological techniques like cold therapy or mindfulness, can further enhance pain relief. Close follow-up is essential to adjust the treatment as needed and ensure the patient's pain is well-controlled.
Diabetes and Stem Cells: What Does the Future Hold?
The future of diabetes treatment may be revolutionized by stem cell research, offering hope for a long-term cure. Scientists are developing stem cell therapies that could regenerate insulin-producing beta cells in the pancreas, potentially restoring natural insulin production in people with type 1 diabetes. Early clinical trials have shown promising results, with some patients reducing or eliminating their need for insulin injections. While challenges like immune rejection and long-term efficacy remain, continued advancements suggest stem cell therapy could significantly change diabetes management in the coming years.